Routine board refresh with no financial or operational implications. Monitor for any future 8-Ks related to committee changes or strategic shifts, but no immediate trading action warranted.
Price Chart
Executive Summary
IDT Corp filed an 8-K reporting the resignation of director Irwin Katsof (not due to any disagreement) and the appointment of William Conkling to the board. Conkling, a former CEO of Rafael Holdings and current CCO of Protara Therapeutics, will serve as Audit Committee Chair and Audit Committee Financial Expert. This is a routine board refresh with no material financial impact.
Key Facts
- Irwin Katsof resigned from the board on June 9, 2026; resignation was not due to any disagreement with the company
- William Conkling, age 55, appointed to the board on June 9, 2026; term expires at the 2026 annual meeting
- Conkling is independent per NYSE standards and will serve as Audit Committee Chair, Audit Committee Financial Expert, and member of Compensation and Corporate Governance Committees
- Conkling is currently Chief Commercial Officer of Protara Therapeutics and previously served as CEO of Rafael Holdings (NYSE: RFL) from Feb 2022 to May 2025
- Conkling is eligible for the standard Non-Employee Director Compensation Program (cash and equity awards)
Financial Impact
No financial figures disclosed; routine director compensation only
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-020335 |
| Document: 0001437749-26-020335-index-headers.html | 0001437749-26-020335 |
| Document: 0001437749-26-020335-index.html | 0001437749-26-020335 |
| Document: 0001437749-26-020335.txt | 0001437749-26-020335 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 29d ago | Press Release | $68.73 $79.97 | ▲ +16.35% | ▲ +17.47% | $78.98 (+14.91%) |
Aug 24, 2026 5w ago | Press Release | $69.38 $68.84 | ▼ −0.78% | ▼ −2.02% | $78.98 (+13.84%) |
Jul 21, 2026 10w ago | Insider Cluster | $63.35 $66.65 | ▲ +5.21% | ▲ +2.65% | $78.98 (+24.67%) |
Jul 1, 2026 13w ago | Insider Cluster | $57.95 $67.10 | ▲ +15.79% | ▲ +17.98% | $78.98 (+36.29%) |
Jun 15, 2026 15w ago | Insider Cluster | $52.76 $61.40 | ▲ +16.38% | ▲ +17.13% | $78.98 (+49.70%) |
Jun 11, 2026 16w ago | Institutional Cluster | $54.63 $61.10 | ▲ +11.84% | ▲ +10.06% | $78.98 (+44.57%) |
Jun 11, 2026 16w ago | 8-K | $54.63 $61.10 | ▲ +11.84% | ▲ +10.06% | $78.98 (+44.57%) |
Jun 10, 2026 16w ago | Press Release | $55.50 $59.97 | ▲ +8.05% | ▲ +4.43% | $78.98 (+42.31%) |
Jun 3, 2026 17w ago | 8-K | $55.57 $58.82 | ▲ +5.85% | ▲ +7.22% | $78.98 (+42.13%) |
Jun 3, 2026 17w ago | Press Release | $54.03 $58.82 | ▲ +8.87% | ▲ +9.87% | $78.98 (+46.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access